Logo

COTA Research Showcased High Concordance Rate Between Real-World Physician Response Assessment & the 2017 European LeukemiaNet (ELN) Criteria for Acute Myeloid Leukemia at EHA2022

COTA’s recent collaboration with University of Texas Southwestern Medical Center produced an analysis about Acute myeloid leukemia.

This study looked at the concordance of physician-assessed response in the COTA real-world database to derived response using the 2017 ELN criteria as the established standard for response assessment in clinical trials. They found that overall agreement between response categories was 65.1% with the highest agreement among CR (61.7%). In the subset of ELN eligible population the overall response was 80% for derived responders and 79% for physician-assessed responders.